Clinical Trial Update: Reusable Face Masks to Reduce Risk of Viral Respiratory Infections and Asthma Exacerbations [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating reusable face masks to reduce viral respiratory infections and asthma exacerbations has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Respiratory Infection

Snippet

Sponsor: Queen Mary University of London | Conditions: Acute Respiratory Infection, Asthma Exacerbations | Phase 2 | Status: WITHDRAWN